Towards automated production and drug sensitivity testing using scaffold‐free spherical tumor microtissues

Biotechnology Journal - Tập 6 Số 12 - Trang 1488-1496 - 2011
Maren Drewitz1, Marianne M. Helbling1, Nicole Fried1, Manuela Bieri1, Wolfgang Moritz1, Jan Lichtenberg1, Jens M. Kelm1
1Insphero AG, Zürich, SWITZERLAND

Tóm tắt

AbstractAlthough the relevance of three‐dimensional (3‐D) culture has been recognized for years and exploited at an academic level, its translation to industrial applications has been slow. The development of reliable high‐throughput technologies is clearly a prerequisite for the industrial implementation of 3‐D models. In this study the robustness of spherical microtissue production and drug testing in a 96‐well hanging‐drop multiwell plate format was assessed on a standard 96‐well channel robotic platform. Microtissue models derived from six different cell lines were produced and characterized according to their growth profile and morphology displaying high‐density tissue‐like reformation and growth over at least 15 days. The colon cancer cell line HCT116 was chosen as a model to assess microtissue‐based assay reproducibility. Within three individual production batches the size variations of the produced microtissues were below 5%. Reliability of the microtissue‐based assay was tested using two reference compounds, staurosporine and chlorambucil. In four independent drug testings the calculated IC50 values were benchmarked against 2‐D multiwell testings displaying similar consistency. The technology presented here for the automated production of a variety of microtissues for efficacy testing in a standard 96‐well format will aid the implementation of more organotypic models at an early time point in the drug discovery process.

Từ khóa


Tài liệu tham khảo

10.1038/424870a

10.1038/sj.onc.1203782

10.1038/35094059

Kerbel R., 1996, Induction and reversal of cell adhesion‐dependent multicellular drug resistance in solid breast tumors., Hum. Cell, 9, 257

10.1080/09553000701727531

Hirschhaeuser F., 2010, Multicellular tumor spheroids: An underestimated tool is catching up again., J. Biotechnol., 5402, 13

10.1007/978-3-642-82340-4_2

10.1016/S1040-8428(00)00076-7

10.1016/j.pharmthera.2006.08.001

10.2174/0929867013372959

Kennedy K., 1987, Hypoxic cells as specific drug targets for chemotherapy, Anticancer Drug Des., 2, 181

10.1074/jbc.M109.006478

10.1158/1535-7163.MCT-06-0024

10.1038/nrc3064

10.1016/j.bcp.2003.07.016

10.1083/jcb.137.1.231

10.1186/bcr2725

10.1038/onc.2008.394

10.1073/pnas.0507681102

10.1016/j.bios.2006.03.016

10.1038/nbt1361

10.1203/01.pdr.0000305937.26105.e7

10.1002/bit.22361

10.1016/S0142-9612(03)00340-5

10.1073/pnas.0708756105

10.1111/j.1432-0436.1991.tb00255.x

10.1016/0955-0674(95)80071-9

10.1016/j.tibtech.2004.02.002

10.1038/nrm2236

10.1016/j.drudis.2008.11.006

10.1016/j.jala.2006.08.003

10.1002/bit.10655

10.1007/s10456-004-8911-7

Sutherland R., 1986, Oxygenation and differentiation in multicellular spheroids of human colon carcinoma., Cancer Res., 46, 5320

10.1126/science.8493529

Comley J. 3D cell culture easier said than done! DDW Drug Discovery World2010 25–41.

10.1016/j.biotechadv.2009.02.002

10.1016/S0304-3835(98)00198-0